Forth secures funding from the Development Bank of Wales and regional angels to expand its health-tech platform.
The investment from the Development Bank of Wales and regional angels will fund platform development and customer acquisition.
Forth provides biochemistry tracking and health insights with a focus on female hormonal health.
Health technology company Forth has secured backing from the Development Bank of Wales alongside a syndicate of angel investors from Angels Invest Wales and the South West. The company, which is relocating its base from Bristol to Chepstow, provides at-home finger-prick blood testing services aimed at tracking individual wellbeing and athletic performance.
Funding will be directed towards developing the company's technology platform and expanding its customer base. The investment marks a homecoming for chief executive Sarah Bolt, who is originally from Cardiff and has built the business outside the traditional London-centric funding hubs.
From the founder
"We are delighted to secure Development Bank of Wales as an investor. This investment will be used to develop our technology platform and recruit more customers to our service."
Sarah Bolt
CEO and Co-founder at Forth
Investor perspective
"Following on from the incredible success of Creo Medical, it’s great to have attracted another exciting business to Wales and to co-invest again with some of the angels who backed Creo from the beginning."
Richard Thompson
Senior Investment Executive, Development Bank of Wales
Use of funds
- 01Continue product development
- 02Accelerate go-to-market
